Derleme
BibTex RIS Kaynak Göster

Current Novel Nanocarriers in Drug Delivery: A Review

Yıl 2022, Cilt: 42 Sayı: 4, 238 - 256, 01.12.2022
https://doi.org/10.52794/hujpharm.1075668

Öz

Nanotechnology’s applicability in medicine, specifically drug delivery, is expected to grow substantially. Because of their ability to overcome drug transportation constraints, nanotechnology in drug transport systems could be a possible technique for overcoming traditional drug delivery. A targeted Drug Delivery system can enhance the transport and nearby awareness of drugs. Targeted transport processes for most cancer therapeutics have proven a steep upward push over the beyond few decades. However, in comparison to the plethora of hit pre-scientific studies, the best passively centered Nanocarriers (NCs) had been accredited for scientific use and none of the actively centered NCs have superior beyond scientific trials. Herein, we overview the principles at the back of centered transport processes to decide the ability motives for restrained scientific translation and success. We advocate standards and concerns that ought to be taken into account for the improvement of novel actively centered NCs. We additionally spotlight the possible instructions for the improvement of a hit tumor and concentrated on strategies.

Kaynakça

  • 88. Li, X., Wang, C., Tan, H., Cheng, L., Liu, G., Yang, Y., et al. (2016). Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques. Biomaterials 108, 71–80.
  • 89. Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Nanotechnology. 2011;22:455102.
  • 90. Bimbo LM. Biocampatability and Biofunctionalization of Mesoporous Silicon Particles. Finland: Divi of Pharmaceutical Technology, University of Helsiniki; 2012.
  • 91. Shah A, Saima A, Jan N, Naeem A, Iftikhar F. Nanocarriers for targeted drug delivery,J Drug Deliv Sci Technol, 62,2021, 1773-2247

Current Novel Nanocarriers in Drug Delivery: A Review

Yıl 2022, Cilt: 42 Sayı: 4, 238 - 256, 01.12.2022
https://doi.org/10.52794/hujpharm.1075668

Öz

Nanotechnology’s applicability in medicine, specifically drug delivery, is expected to grow substantially. Because of their ability to overcome drug transportation constraints, nanotechnology in drug transport systems could be a possible technique for overcoming traditional drug delivery. A targeted Drug Delivery system can enhance the transport and nearby awareness of drugs. Targeted transport processes for most cancer therapeutics have proven a steep upward push over the beyond few decades. However, in comparison to the plethora of hit pre-scientific studies, the best passively centered Nanocarriers (NCs) had been accredited for scientific use and none of the actively centered NCs have superior beyond scientific trials. Herein, we overview the principles at the back of centered transport processes to decide the ability motives for restrained scientific translation and success. We advocate standards and concerns that ought to be taken into account for the improvement of novel actively centered NCs. We additionally spotlight the possible instructions for the improvement of a hit tumor and concentrated on strategies.

Kaynakça

  • 88. Li, X., Wang, C., Tan, H., Cheng, L., Liu, G., Yang, Y., et al. (2016). Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques. Biomaterials 108, 71–80.
  • 89. Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Nanotechnology. 2011;22:455102.
  • 90. Bimbo LM. Biocampatability and Biofunctionalization of Mesoporous Silicon Particles. Finland: Divi of Pharmaceutical Technology, University of Helsiniki; 2012.
  • 91. Shah A, Saima A, Jan N, Naeem A, Iftikhar F. Nanocarriers for targeted drug delivery,J Drug Deliv Sci Technol, 62,2021, 1773-2247
Toplam 4 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Eczacılık ve İlaç Bilimleri
Bölüm Review Articles
Yazarlar

Niharika Lal 0000-0003-4949-004X

Praveen Kumar Gaur Bu kişi benim 0000-0002-4221-1485

Sameer Rastogi Bu kişi benim 0000-0003-4792-3083

Kanak Lata Bu kişi benim 0000-0001-9578-0051

Yayımlanma Tarihi 1 Aralık 2022
Kabul Tarihi 10 Haziran 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 42 Sayı: 4

Kaynak Göster

Vancouver Lal N, Gaur PK, Rastogi S, Lata K. Current Novel Nanocarriers in Drug Delivery: A Review. HUJPHARM. 2022;42(4):238-56.